News & Analysis on Clinical Trial Services & Contract Research And Development
The identification of an oncogene, which is associated with cancers such as leukaemia, could lead to the development of targeted molecular therapeutics, controlling cancer development through regulation of the errant gene.
The ability of Applied Biosystem's 7500 Fast Real-Time PCR System to reduce experimental time by almost three times from 2 hours to approximately 35 minutes, in an industry standard 96-well format, demonstrates the progress this market has made,...
An emerging trend has identified an emergence of combination drugs, which could be a solution to patient non-compliance, a major factor in the rise of drug resistant microorganisms in the industrialised nations.
German biotechnology company MorphoSys' acquisition of two Biogenesis antibody technology companies elevates it to one of the largest European suppliers of antibodies to the life sciences research community.
Pfizer and Rigel Pharmaceuticals have entered into a collaboration to develop a novel class of compounds for the treatment of allergic asthma and other respiratory diseases that continue to see cases rising in Europe and the US.